WASHINGTON UNIVERSITY IN ST. LOUIS SCHOOL OF MEDICINE PEDIATRICS RESEARCH LABS TARR LAB INVESTIGATOR BIO
Pediatrics Research
Developmental Biology and Genetics Pathobiology Patient-Oriented Research
Department of Pediatrics Home
Investigators
Resources
NIH Projects
Seminars/Meetings
Research News
Philanthropy
Join Us

Investigator Bio



 
             Picture of Phillip I. Tarr, M.D.
 
 
 
Phillip I. Tarr, M.D.    contact information ]

Melvin E. Carnahan Professor of Pediatrics; Unit Leader Pathobiology; Director Division of Pediatric Gastroenterology and Nutrition

Education

  • A.B., Brown University, 1975
  • M.D., Yale University, 1980

Training

  • Pediatric Residency, University of Washington, Seattle, Wa., 1980-83
  • Assistant Chief Resident, Department of Pediatrics, University of Washington School of Medicine/Children's Orthopedic Hospital and Medical Center, Seattle, Wa., 1982-83
  • Infectious Diseases Fellowship, University of Washington, Seattle, Wa., 1983-87
  • Senior Fellow, Division of Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Wa., 1983-86
  • Research Associate, Seattle Biomedical Research Institute, Seattle, Wa., 1986-87
  • Gastroenterology Fellowship, University of Washington, Seattle, Wa., 1988-89

Licensure and Board Certification

  • Washington License, 1981
  • Missouri License, 2003
  • American Board of Pediatrics, 1984
  • Pediatric Gastroenterology, 1993
  • Pediatric Gastroenterology (Re-certification), 1999

Selected Publications

  1. Bielaszewska, M., Zhang, W., Tarr PI, P. I., Sonntag, A. K. & Karch, H.: Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates. J Clin Microbiol 43 4225-8 (2005).

  2. Ake, J. A. et al.: Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 115 e673-80 (2005).

  3. John, M. et al.: Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection. Infect Immun 73, 2665-79 (2005).

  4. Tarr PI, Gordon, C. A. & Chandler, W. L.: Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073-86 (2005).

  5. Johnson, J. R. et al. : The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. J Infect Dis 188, 719-29 (2005).

  6. Jelacic, J. K. et al: Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J Infect Dis 188, 719-29 (2003).

  7. Johnson, J. R., Lockman, H. A., Owens, K., Jelacic, S. & Tarr PI: High-frequency secondary mutations after suicide-driven allelic exchange mutagenesis in extraintestinal pathogenic Escherichia coli. J Bacteriol 185, 5301-5 (2003).

  8. Shaikh, N. & Tarr PI: Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications. J Bacteriol 185, 3596-605 (2003).


 or TOP

Washington University School of Medicine Logo
©2001-2005 Washington University in St. Louis, School of Medicine, Department of Pediatrics
pediatrics directory | webmaster@kids.wustl.edu | reporting copyright problems | 2004-04-21 12:22:19


4.0t
css